96.8 per cent is at the top of what stepwise synthesis delivers on a chain this long, and it is reachable rather than fictional. Every coupling is high-yielding and none is quantitative, so the deletion and truncation sequences that survive purification are what occupies the remaining 3.2 per cent. Above roughly 98 per cent you are fighting the purification rather than the synthesis, which is why a 96.8 per cent figure on tirzepatide deserves a method question — column, gradient, wavelength — rather than either belief or dismissal.
Identity and purity are orthogonal, and a high purity says almost nothing about whether the peak is actually what you think it is.
Sample solvent strength affects peak shape — if you inject in strong solvent on a gradient starting in weak solvent, the solvent peak can distort your main peak or create a false shoulder.
It helps to be literal here: the fraction of your main peak that is actually your target versus isomers, fragments or related sequences is invisible without complementary identity testing.
The Arrhenius relationship for peptide degradation is the basis of accelerated stability testing and also governs how quickly methods drift with temperature.
Compare purity within a single laboratory on the same method, never across laboratories.
edited 5 Aug 2026 by ilaria_bertone — added the method parameters